Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹59.2 Cr 17.6% -9.3% -52.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,997.7 Cr -3.2% -13.1% -20.7% Stock Analytics
KIRI INDUSTRIES ₹2,252.4 Cr -0.1% -17% -42% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,573.3 Cr 12.2% 1.6% -30% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,003.9 Cr -0.7% -2.1% 13.9% Stock Analytics
BODAL CHEMICALS ₹694.1 Cr -3.5% 17.6% -11.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

17.6%

-9.3%

-52.3%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses